Altavo GmbH, a med­ical tech­nol­ogy startup for AI-based voice reha­bil­i­ta­tion, has closed a Series A2 financ­ing round. A Euro­pean con­sor­tium led by Novalis Biotech and bm|t is invest­ing € 3 mil­lion in the devel­op­ment of Altavo’s inno­v­a­tive arti­fi­cial voice.